Challenges in diagnosing drug-resistant tuberculosis (DR-TB) contribute to a diagnostic gap. Design-locked Targeted Sequencing (TS) assays have the potential to improve DR-TB diagnosis and management.
ObjectiveThis study aims to explore factors influencing false-negative results in Interferon-Gamma Release Assay (IGRA) for patients with Pulmonary Tuberculosis (PTB), and develop a nomogram model to
Understanding the factors leading each stakeholder to participate in an experimental trial is a key element for improving trial set-up and for identifying selection bias in statistical analyses. An ex
NOTE. Clinical diagnosis, Categorization of patients and controls as describe in methods; PPV, positive predictive value; NPV, negative predictive value; Sensitivity, TP/(TP+ FN) x 100, where T is tru
